Private Wealth Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,275
Closed -$31K 1098
2025
Q2
$31K Buy
1,275
+525
+70% +$11.5K ﹤0.01% 472
2025
Q1
$15.6K Buy
+750
New +$18.8K ﹤0.01% 550

Other funds holding ARKG

Private Wealth Asset Management's ARKG Position: Q3 2025 in Review

Private Wealth Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2025, closing a stake of 1,275 shares — an estimated $31K sold.

Private Wealth Asset Management first reported a position in ARKG in Q1 2025 and held it in 2 quarters. The position peaked at $31K in Q2 2025. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • Private Wealth Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2025 after selling out during the quarter.
  • Private Wealth Asset Management sold 1,275 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $31K.
  • Private Wealth Asset Management first reported a position in ARK Genomic Revolution ETF in Q1 2025 and held it in 2 quarters.
  • Private Wealth Asset Management's ARK Genomic Revolution ETF position peaked at $31K in Q2 2025.
  • 231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on Private Wealth Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.